Praktické lékárenství – 1/2020

www.praktickelekarenstvi.cz e55 NEMOCNIČNÍ LÉKÁRENSTVÍ ÚPRAVA DÁVKY CHEMOTERAPIE U PACIENTA PO AMPUTACI HORNÍ A DOLNÍ KONČETINY PRAKTICKÉ LÉKÁRENSTVÍ LITERATURA 1. Vyzula R a kol. Modrá kniha České onkologické společnosti. Brno: Masarykův onkologic- ký ústav, 2018: 260 s. 2. Gurney H. How to calculate the dose of chemotherapy. British Journal of Cancer. 2002; 86(8): 1297 – 1302. 3. Sacco JJ, et al. The average body surface area of adult cancer patients in the UK: a mul- ticentre retrospective study. PloS One. 2010; 5(1): e8933. 4. Mosteller RD. Simplified Calculation of Body-Surface Area. The New England Journal of Me- dicine. 1987; 317(17): 1098 – 1098. 5. Haycock GB, et al. Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adults. The Journal of Pediatrics. 1978; 93(1): 62 – 66. 6. Výpočet hmotností segmentů lidského těla. BIOMECH.FTVS.CUNI.CZ [online]. [cit. 2018- 09-10] Dostupné z: http://biomech.ftvs.cuni.cz / pbpk/kompendium/biomechanika/geo- metrie_hmotnost_vypocet.php. 7. Owen D, et al. Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma. Gastrointestinal Cancer Research: GCR. 2013; 6(3): 93. 8. Hutson PR. Using body surface area adjustments in amputees. American Journal of Hos- pital Pharmacy. 1985; 42(5): 1048. 9. Wallace AB. The exposure treatment of burns. The Lancet. 1951; 257(6653): 501–504. 10. Smith JJ, et al. A comparison of serial halving and the rule of nines as a pre-hospital assessment tool in burns. British Journal of Plastic Surgery. 2005; 58(7): 957–967. 11. Colangelo PM, et al. Two methods for estimating body surface area in adult amputees. American Journal of Hospital Pharmacy. 1984;. 41(12): 2650. 12. O‘Marcaigh, AS, et al. Variation in the practice of dose reduction of chemotherapeutic agents after weight loss or amputation. Journal of Pediatric hematology/oncology. 1995; 17(2): 172–175. 13. O‘Marcaigh AS, et al. Dose reduction of chemotherapeutic agents after weight loss. American Journal of Clinical Oncology. 1997; 20(2): 193–195.